Jonathan Monson - Mar 31, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Mar 31, 2023
Transactions value $
-$185,550
Form type
4
Date filed
3/31/2023, 04:30 PM
Previous filing
Mar 2, 2023
Next filing
Jul 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $64.5K +5K +14.34% $12.89 39.9K Mar 31, 2023 Direct F1
transaction BSX Common Stock Sale -$250K -5K -12.54% $50.00 34.9K Mar 31, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -5K -100% $0.00* 0 Mar 31, 2023 Common Stock 5K $12.89 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 30, 2022.
F2 Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock.